Other Guidelines | Page 35 | European Cystic Fibrosis Society (ECFS)

Drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

Using a digital system, CFHealthHub, to automatically record the use of preventative inhaled treatments as to compare the amount of medicines collected from pharmacy to the amount actually used.

Comparing lung function testing at home vs in the clinic.

A review of sweat testing in Ireland in the era of modern CF care

Sense of Smell in People with Cystic Fibrosis: Impact of Modulator Therapy

A review of three studies examining different aspects of pulmonary exacerbation treatment

Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?

The role of CF dietitians to help infants meet nutrition goals

Survival in cystic fibrosis after need for mechanical life support.

The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

first
previous
…
31
32
33
34
35
36
37
38
39
…
next
last